NCT06764342

Brief Summary

The present study aims to evaluate bad breath in patients undergoing gingival treatment combined with tongue scraping and laser and to assess its potential benefits for both periodontal and microbiological condition. Firs patients will be selected among those who participated in a privies study. Additional patients will be also invited. They must have gum disease and bad breath. Treatments will be completed within 24 hours and oral samples will be collected with thin paper points. Bad breath will be evaluated by a professional and a specific gas machine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

January 8, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

December 22, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

January 2, 2025

Last Update Submit

December 18, 2025

Conditions

Keywords

halitosisperiodontitisfull-mouth disinfectionantimicrobial photodynamic therapyreal time polymerase chain reactionbacteria

Outcome Measures

Primary Outcomes (1)

  • sulfur volatile compounds changes

    pre and post-treatment changes in levels (parts per billion) of CH3SH, a sulfur volatile compound

    baseline versus 21 and 45 days after treatment

Secondary Outcomes (3)

  • Changes in periodontal probing depth

    baseline versus 45 days after treatment

  • Changes in organoleptic testing

    Baseline versus 45 days after treatment

  • Changes in tongue total bacteria count

    baseline versus 45 days after treatment

Study Arms (2)

Full-mouth scaling

ACTIVE COMPARATOR

Full-mouth ultrasonic and manual periodontal instrumentation

Procedure: full-mouth scaling

Full-mouth scaling combined with antimicrobial photodynamic therapy

EXPERIMENTAL

Full-mouth ultrasonic and manual periodontal instrumentation combined with antimicrobial photodynamic therapy applied to tongue dorsum and periodontal pockets

Radiation: Full-mouth scaling combined with antimicrobial photodynamic therapy

Interventions

Full-mouth scaling within 24 hours, divided into two sessions of ultrasonic instrumentation followed by manual supra- and subgingival scaling and root planing. Tongue cleaning was performed with a tongue scraper.

Full-mouth scaling

After full-mouth scaling procedures antimicrobial photodynamic therapy was carried out using a laser-activated disinfection device with a red laser emission (wavelength: 630 nm, irradiance: 2000-4000 mW/cm², spot size at the probe tip: 8 mm diameter) and high-viscosity methylene blue gel (0.1 mg/mL) which was applied at six spots on the tongue dorsum. Antimicrobial photodynamic therapy was also applied iIn sites with altered periodontal pocket depth (≥ 4mm). The dye remained in the pockets for 10 minutes to ensure full absorption and its excess was rinsed with sterile saline after laser exposure.

Full-mouth scaling combined with antimicrobial photodynamic therapy

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-reported halitosis;
  • organoleptic score \>2;
  • stage III periodontitis;
  • at least 14 teeth.

You may not qualify if:

  • smokers or former smokers;
  • individuals diagnosed with diabetes and/or immune diseases;
  • pregnant or lactating women;
  • individuals with removable partial dentures and/or fixed or removable orthodontic appliances;
  • systemic use of antibiotics or anti-inflammatory drugs in the last three months; - individuals who required prophylactic antibiotics for periodontal exams and treatments;
  • individuals who regularly used or had used any type of mouthwash in the past three months;
  • individuals who underwent periodontal treatment in the six months prior to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Minas Gerais, Dental School

Belo Horizonte, Minas Gerais, 31270-901, Brazil

Location

MeSH Terms

Conditions

PeriodontitisHalitosis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fernando O Costa, doctorate

    Federal University of Minas Gerais, Dental School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
titular professor

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 8, 2025

Study Start

January 8, 2025

Primary Completion

February 22, 2025

Study Completion

June 25, 2025

Last Updated

December 22, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Data will be analyzed by group and using numerical codes avoiding individual personal data identification. Data access will be protected by password.

Locations